Literature DB >> 23142168

Comparison of the SUPERCARBA, CHROMagar KPC, and Brilliance CRE screening media for detection of Enterobacteriaceae with reduced susceptibility to carbapenems.

Delphine Girlich1, Laurent Poirel, Patrice Nordmann.   

Abstract

The recently developed SUPERCARBA medium was evaluated together with 2 commercially available selective culture media containing carbapenems: CHROMagar KPC (CHROMagar) and Brilliance CRE (Oxoid, Thermofisher Scientific). A total of 142 enterobacterial isolates were tested, including 131 isolates with reduced susceptibility to carbapenems. The SUPERCARBA medium has the highest sensitivity (96.5%) (detecting virtually all carbapenemase producers including OXA-48-like producers) as compared to Brilliance CRE (76.3%) and CHROMagar KPC (43%). The specificity of the screening media was similar, ranging from 57% to 68%.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23142168     DOI: 10.1016/j.diagmicrobio.2012.10.006

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  22 in total

1.  Clinical Performance of Check-Direct CPE, a Multiplex PCR for Direct Detection of bla(KPC), bla(NDM) and/or bla(VIM), and bla(OXA)-48 from Perirectal Swabs.

Authors:  Anna F Lau; Gary A Fahle; Margaret A Kemp; Agatha N Jassem; John P Dekker; Karen M Frank
Journal:  J Clin Microbiol       Date:  2015-09-02       Impact factor: 5.948

Review 2.  Intestinal Carriage of Carbapenemase-Producing Organisms: Current Status of Surveillance Methods.

Authors:  Roberto Viau; Karen M Frank; Michael R Jacobs; Brigid Wilson; Keith Kaye; Curtis J Donskey; Federico Perez; Andrea Endimiani; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

3.  Rapid and direct real-time detection of blaKPC and blaNDM from surveillance samples.

Authors:  Shawn Vasoo; Scott A Cunningham; Peggy C Kohner; Jayawant N Mandrekar; Karen Lolans; Mary K Hayden; Robin Patel
Journal:  J Clin Microbiol       Date:  2013-08-21       Impact factor: 5.948

4.  Carbapenem-Resistant Enterobacteriaceae: Laboratory Detection and Infection Control Practices.

Authors:  Eva-Brigitta Kruse; Ute Aurbach; Hilmar Wisplinghoff
Journal:  Curr Infect Dis Rep       Date:  2013-10-12       Impact factor: 3.725

Review 5.  A Decade of Development of Chromogenic Culture Media for Clinical Microbiology in an Era of Molecular Diagnostics.

Authors:  John D Perry
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

6.  Evaluation of a new chromogenic medium, chromID OXA-48, for recovery of carbapenemase-producing Enterobacteriaceae from patients at a university hospital in Turkey.

Authors:  P Zarakolu; K M Day; H E Sidjabat; W Kamolvit; C V Lanyon; S P Cummings; D L Paterson; M Akova; J D Perry
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-10-12       Impact factor: 3.267

7.  Act Fast as Time Is Less: High Faecal Carriage of Carbapenem-Resistant Enterobacteriaceae in Critical Care Patients.

Authors:  Sanjith Saseedharan; Manisa Sahu; Edwin Joseph Pathrose; Sarita Shivdas
Journal:  J Clin Diagn Res       Date:  2016-09-01

Review 8.  Carbapenemase-producing Enterobacteriaceae in animals and methodologies for their detection.

Authors:  Rebecca E V Anderson; Patrick Boerlin
Journal:  Can J Vet Res       Date:  2020-01       Impact factor: 1.310

9.  Characteristics of extended-spectrum β-lactamase- and carbapenemase-producing Enterobacteriaceae Isolates from rivers and lakes in Switzerland.

Authors:  Katrin Zurfluh; Herbert Hächler; Magdalena Nüesch-Inderbinen; Roger Stephan
Journal:  Appl Environ Microbiol       Date:  2013-03-01       Impact factor: 4.792

Review 10.  Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases.

Authors:  L Silvia Munoz-Price; Laurent Poirel; Robert A Bonomo; Mitchell J Schwaber; George L Daikos; Martin Cormican; Giuseppe Cornaglia; Javier Garau; Marek Gniadkowski; Mary K Hayden; Karthikeyan Kumarasamy; David M Livermore; Juan J Maya; Patrice Nordmann; Jean B Patel; David L Paterson; Johann Pitout; Maria Virginia Villegas; Hui Wang; Neil Woodford; John P Quinn
Journal:  Lancet Infect Dis       Date:  2013-09       Impact factor: 25.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.